Health
Prior use of renin-angiotensin system inhibitors linked to reduced risk of death in older COVID-19 patients with hypertension – News-Medical.Net
A new study, appearing as a preprint on the medRxiv* server, demonstrates the protective effect of drugs in older COVID-19 patients with hypertension.
The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The virus binds to the target host cell via the angiotensin-converting enzyme 2 (ACE2). This receptor is also part of the renin-angiotensin system (RAS) that regulates the cardiovascular system and renal function.
ACE2 is a RAS inhibitor. Some animal studies show that among the RAS inhibitors (RASIs), some may increase ACE2 levels, thus promoting viral entry into human…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General17 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General12 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
Business19 hours agoSolid superannuation gains continue to roll in